LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 90.55 | 27.76 | 3 | 6928 | 0.0004 | -0.2438 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 90.55 | 27.76 | 583 | 6928 | 0.0841 | 0.4657 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 90.55 | 27.76 | 1 | 6928 | 0.0001 | -0.3412 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 90.55 | 27.76 | 413 | 6928 | 0.0596 | 0.4036 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 92.25 | 27.76 | 5 | 6873 | 0.0007 | -0.1939 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 92.25 | 27.76 | 580 | 6873 | 0.0844 | 0.4656 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 92.25 | 27.76 | 1 | 6873 | 0.0001 | -0.3416 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 92.25 | 27.76 | 382 | 6873 | 0.0556 | 0.3906 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 93.96 | 27.76 | 4 | 6849 | 0.0006 | -0.2163 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 93.96 | 27.76 | 588 | 6849 | 0.0859 | 0.4684 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 93.96 | 27.76 | 1 | 6849 | 0.0001 | -0.3418 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 93.96 | 27.76 | 397 | 6849 | 0.0580 | 0.3976 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 95.66 | 27.76 | 2 | 6712 | 0.0003 | -0.2827 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 95.66 | 27.76 | 588 | 6712 | 0.0876 | 0.4705 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 95.66 | 27.76 | 1 | 6712 | 0.0001 | -0.3428 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 95.66 | 27.76 | 340 | 6712 | 0.0507 | 0.3722 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | I10 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 1.95 | 27.76 | 776 | 225 | 3.4467 | 2.0129 | MN20160318_Q01 | I10 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | N17 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 1.95 | 27.76 | 697 | 225 | 3.0958 | 1.9077 | MN20160318_Q01 | N17 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | I10 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 3.66 | 27.76 | 831 | 283 | 2.9268 | 1.7546 | MN20160318_Q01 | I10 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | N17 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 3.66 | 27.76 | 782 | 283 | 2.7542 | 1.7052 | MN20160318_Q01 | N17 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | I10 |